30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

A Final Look at 2010 Results:

BACTERIN
$15.4MM, +~109%
* Tissue Sales $15.2MM, +114%
* Royalties/Other $0.2MM, -30%

4Q10 revenue:
$5.3MM, +~141%
* Tissue Sales $5.2MM, +150%
* Royalties/Other $0.9MM, -88%

* Secured ~$15MM in funding
* OsteoSponge ~45%-50% of 2010 revenue
* Launched OsteoSelect DBM Putty, OsteoSponge SC, hMatrix
* Increased direct and indirect biologics sales force by >150% (includes 52 biologics sales reps, will grow to 64 by end of 2011)